desipramine has been researched along with Bleeding in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lechin, F | 1 |
| van der Dijs, B | 1 |
| Orozco, B | 1 |
| Jahn, E | 1 |
| Rodriguez, S | 1 |
| Baez, S | 1 |
1 other study available for desipramine and Bleeding
| Article | Year |
|---|---|
Neuropharmacological treatment of refractory idiopathic thrombocytopenic purpura: roles of circulating catecholamines and serotonin.
Topics: Adult; Blood Platelets; Catecholamines; Child; Desipramine; Female; Hemorrhage; Humans; Male; Middle | 2004 |